TGFβ-SMAD signal transduction:: molecular specificity and functional flexibility

被引:1021
作者
Schmierer, Bernhard [1 ]
Hill, Caroline S. [1 ]
机构
[1] Canc Res UK London Res Inst, Dev Signalling Lab, London WC2A 3PX, England
关键词
D O I
10.1038/nrm2297
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Ligands of the transforming growth factor-beta (TGF beta) superfamily of growth factors initiate signal transduction through a bewildering complexity of ligand-receptor interactions. Signalling then converges to nuclear accumulation of transcriptionally active SMAD complexes and gives rise to a plethora of specific functional responses in both embryos and adult organisms. Current research is focused on the mechanisms that regulate SMAD activity to evoke cell-type-specific and context-dependent transcriptional programmes. An equally important challenge is understanding the functional role of signal strength and duration. How are these quantitative aspects of the extracellular signal regulated? How are they then sensed and interpreted, and how do they affect responses?.
引用
收藏
页码:970 / 982
页数:13
相关论文
共 141 条
  • [51] The MAD-related protein Smad7 associates with the TGF beta receptor and functions as an antagonist of TGF beta signaling
    Hayashi, H
    Abdollah, S
    Qiu, YB
    Cai, JX
    Xu, YY
    Grinnell, BW
    Richardson, MA
    Topper, JN
    Gimbrone, MA
    Wrana, JL
    Falb, D
    [J]. CELL, 1997, 89 (07) : 1165 - 1173
  • [52] Hematopoiesis controlled by distinct TIF1γ and Smad4 branches of the TGFβ pathway
    He, Wei
    Dorn, David C.
    Erdjument-Bromage, Hediye
    Tempst, Paul
    Moore, Malcolm A. S.
    Massagué, Joan
    [J]. CELL, 2006, 125 (05) : 929 - 941
  • [53] FOLLISTATIN, AN ANTAGONIST OF ACTIVIN, IS EXPRESSED IN THE SPEMANN ORGANIZER AND DISPLAYS DIRECT NEURALIZING ACTIVITY
    HEMMATIBRIVANLOU, A
    KELLY, OG
    MELTON, DA
    [J]. CELL, 1994, 77 (02) : 283 - 295
  • [54] The bone morphogenetic protein I/Tolloid-like metalloproteinases
    Hopkins, Delana R.
    Keles, Sunduz
    Greenspan, Daniel S.
    [J]. MATRIX BIOLOGY, 2007, 26 (07) : 508 - 523
  • [55] Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-β receptor activity
    Inman, GJ
    Nicolás, FJ
    Hill, CS
    [J]. MOLECULAR CELL, 2002, 10 (02) : 283 - 294
  • [56] SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7
    Inman, GJ
    Nicolás, FJ
    Callahan, JF
    Harling, JD
    Gaster, LM
    Reith, AD
    Laping, NJ
    Hill, CS
    [J]. MOLECULAR PHARMACOLOGY, 2002, 62 (01) : 65 - 74
  • [57] Negative regulation of TGF-β receptor/Smad signal transduction
    Itoh, Susumu
    ten Dijke, Peter
    [J]. CURRENT OPINION IN CELL BIOLOGY, 2007, 19 (02) : 176 - 184
  • [58] Morphogen gradient interpretation by a regulated trafficking step during ligand-receptor transduction
    Jullien, J
    Gurdon, J
    [J]. GENES & DEVELOPMENT, 2005, 19 (22) : 2682 - 2694
  • [59] A self-enabling TGFβ response coupled to stress signaling:: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells
    Kang, YB
    Chen, CR
    Massagué, J
    [J]. MOLECULAR CELL, 2003, 11 (04) : 915 - 926
  • [60] Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGFβ receptor for degradation
    Kavsak, P
    Rasmussen, RK
    Causing, CG
    Bonni, S
    Zhu, HT
    Thomsen, GH
    Wrana, JL
    [J]. MOLECULAR CELL, 2000, 6 (06) : 1365 - 1375